Surgical versus medical management of multiple endocrine neoplasia (MEN) type I

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 2, 1997, Pages 357-364

  Veldhuis, Johannes D ^a   Norton, Jeffrey A ^b   Wells Jr , Samuel A ^b   Vinik, Aaron I ^c   Perry, Roger R ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOTHIADIAZINE DERIVATIVE; DIAZOXIDE; OMEPRAZOLE;

AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 11Q; ENDOCRINE TUMOR; ESTROGEN THERAPY; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; NOTE; PANCREAS ISLET; PARATHYROIDECTOMY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

HUMANS; ISLETS OF LANGERHANS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROID DISEASES;

EID: 0031026525     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.2.357     Document Type: Note

References (49)

1. Erdheim J. 1903 Zur normalen und pathologischen histologie der glandula thyreoidaea, parathyreoidaea, und hypophysis. Beitr Pathol Anat. 33:158-236.
2. Lips CJM, Vase HF, Lamers CB. 1984 Multiple endocrine neoplasia syndromes. Crit Rev Oncol Hematol. 2:117-184.
3. Veldhuis JD. 1984 The syndrome of multiple endocrine neoplasia type I. In: Santen RJ, Maani A, eds. Diagnosis and Management of endocrine related tumors. Boston: Martinus Nijhoff Publishers; 383-408.
4. Marx SJ, Vinik AI, Santen RJ, Floyd JC, Mills JL, Green J. 1986 Multiple endocrine neoplasia type 1:assessment of laboratory tests to screen for the gene in a large kindred. Medicine. 65:226-241.
5. Veldhuis JD, Green III JE, Kovacs K, Worgul TJ, Murray FT, Hammond JM. 1979 Prolactin-secreting pituitary adenomas: association with multiple endocrine neoplasia, Type I. Am J Med. 67:830-837.
6. Burgess JR, Sheppard JJ, Parameswaran V, Hoffman L, Greenaway TM. 1996 Prolactinomas in a large kindred with multiple endocrine neoplasia type 1: clinical features and inheritance pattern. J Clin Endocrinol Metab. 81:1841-1845.
7. Bystrom C, Larsson C, Blomberg C, et al. 1990 Localization of the MEN 1 gene to a small region within chromosome 11q13 deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1990.
8. Larsson C, Shepherd J, Nakamura Y, et al. 1992 Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest. 89:1344-1349.
9. Calendar A, Cougard P. 1996 Primary hyperparathyroidism: genetic heterogeneity suggesting different pathogenesis in sporadic and familial forms of parathyroid hyperplasia and tumors. Eur J Endocrinol. 134:233-236.
10. Brunt LM, Veldhuis JD, Dilley WG, et al. 1986 Stimulation of insulin secretion by a rapid intravenous calcium infusion in patients with beta cell neoplasms of the pancreas. J Clin Endocrinol Metab. 62:210-216.
11. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. 1996 Spectrum of pituitary disease in multiple endocrine neoplasia type 1 (MEN 1): clinical, biochemical, and radiological features of pituitary disease in a large MEN 1 kindred. J Clin Endocrinol Metab. 81:2642-2646.
12. Wermer P. 1954 Genetic aspects of adenomatosis of endocrine glands. Am J Med. 16:363-371.
13. Diarmuid S, O'Riordain MB, O'Brien T, et al. 1994 Surgical management of insulinoma associated with multiple endocrine neoplasia type 1. World J Surg. 18:488-494.
14. Zollinger RM, Ellison EH. 1955 Primary peptic ulceration of the jejunum associated with islet cell tumors of the pancreas. Ann Surg. 142:709-728.
15. Friesen SR. 1982 Treatment of the Zollinger-Ellison syndrome: a 25-year assessment. Am J Surg. 143:331-338.
16. Stamm B, Hedinger CE, Saremaslani P. 1986 Duodenal and ampullary carcinoid tumors: a report of 12 cases with pathological characteristics, polypeptide content, and relation to the MEN1 syndrome and von Recklinghausen's disease (neurofibromatosis). Virchows Arch [A]. 408:475-489.
17. Pipeleers-Marichal M, Somers G, Willems G, et al. 1990 Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 322:723-727.
18. Weber HC, Venzon DJ, Jaw-Town L, et al. 1995 Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 108:1637-1649.
19. Sheppard BC, Norton JA, Doppman JL, et al. 1989 Management of islet cell tumors in patients with multiple endocrine neoplasia: a prospective study. Surgery. 106:1108-1118.
20. Melvin WS, Johnson JA, Sparks J, et al. 1993 Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery. 114:1183-1188.
21. Zollinger RM, Ellison EC, O'Dorisio TM, et al. 1984 Thirty years' experience with gastrinoma. World J Surg. 8:427-435.
22. Ruszniewski P, Podevin P, Cadiot G, et al. 1993 Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia. Pancreas. 8:295-304.
23. Jensen RT, Gardner JD. 1993 In: Go VLW, DiMango EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA, eds. The pancreas: biology, pathobiology and disease. 2nd ed. New York: Raven; 931-978.
24. Grama D, Skogseid B, Wilander E, et al. 1992 Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment. World J Surg. 16:611-619.
25. Fraker DL, Norton JA, Alexander R, et al. 1994 Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg. 220: 320-330.
26. Vinik AI, Thompson NW. 1986 Controversies with MEN-1 in the management of the Zollinger-Ellison syndrome. Ann Intern Med. 105:956-959.
27. Marx SJ, Vinik AI, Santen RJ, Floyd Jr JC, Mills JL, Green J. 1986 Multiple endocrine neoplasia type I: assessment of laboratory tests to screen for the gene in a large kindred. Medicine (Baltimore). 65:226-241.
28. Benya RV, Metz DC, Venzon DJ, et al. 1994 Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type I. Am J Med. 97:436-444.
29. Vinik AI, Perry RR. Neoplasms of the gastroenteropancreatic endocrine system. In: Holland JF, Frei III E, Bast RC, Kufe DW, Morton DL, Weichselbaum RR, eds. Cancer medicine, 4th ed. Philadelphia: Lea and Febiger. In Press.
30. Consensus Development Conference Panel. 1991 Diagnosis and management of asymptomatic primary hyperparathyroidism: Consensus Development Conference statement. Ann Intern Med. 114:593-597.
31. O'Riordain DS, O'Brien T, Grant CS, et al. 1993 Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery. 114:1031-1039.
32. Wells SA, Farndon JR, Dale JK, et al. 1980 Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation. Ann Surg. 192:451-456.
33. Doherty GM, Doppman JL, Miller DL, et al. 1992 Results of a multidisciplinary strategy for management of mediastinal parathyroid adenoma as a cause of persistent primary hyperparathyroidism. Ann Surg. 215:101-106.
34. Lee VS, Wilkinson Jr RH, Leight Jr GS, Coogan AC, Coleman RE. 1995 Hyperparathyroidism in high risk surgical patients: evaluation with double-phase technetium-99 M (sestamibi) imaging. Radiology. 177:629-633.
35. Norton JA, Cornelius MJ, Doppman JL, et al. 1987 Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. Surgery. 102:958-966.
36. Mignon M, Ruszniewski P, Podevin P, et al. 1993 Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type I. World J Surg. 17:489-497.
37. Pipeleers-Marichal M, Somers G, Willems G, et al. 1990 Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 322:723-727.
38. Norton JA. 1994 Advances in the management of Zollinger-Ellison syndrome. Adv Surg. 27:129-154.
39. Cadiot G, Lehy T, Ruszniewski P, et al. 1993 Gastric endocrine cell evolution in patients with Zollinger-Ellison syndrome: influence of gastrinoma growth and long-term omeprazole treatment. Dig Dis Sci. 38:1307-1317.
40. Debas HT, Soon-Shiong P, McKenzie AD, et al. 1983 Use of secretin in the roentgenologic and biochemical diagnosis of duodenal gastrinoma. Am J Surg. 145:408-411.
41. Vinik A, Moattari R, Cho K, et al. 1990 Transhepatic portal venous catheterization for localization for sporadic and MEN gastrinomas. Surgery. 107:246-255.
42. Thompson NW. 1992 Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN 1 syndrome. Henry Ford Hosp Med J. 40:195-198.
43. Melvin WS, Johnson JA, Sparks J, et al. 1993 Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery. 114:1183-1188.
44. Norton JA. 1994 Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg. 31:89-156.
45. Vinik AI, Pavlic-Renar I. 1993 Insulin-producing tumors. Advances in Endocrinology and Metabolism. 4:1-27.
46. Glaser B, Shapiro B, Fajans SS, Vinik AI. 1988 Effects of secretin on the normal and pathologic beta cell. J Clin Endocrinol Metab. 66:1138-1144.
47. O'Riordain DS, O'Brien T, van Heerden JA, et al. 1994 Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 18:488-494.
48. Friesen SR, Kimmel TT. 1983 Pancreatic polypeptide update: its role in detection of the trait for multiple endocrine adenopathy syndrome type 1 and pancreatic polypeptide-secreting tumors. Surgery. 94:1028-1037.
49. Langstein HN, Norton JA, Chiang H-CV, et al. 1990 The utility of circulating levels of human pancreatic polypeptide as a marker for islet cell tumors. Surgery. 108:1109-1116.